|
|
|
Volumn 8, Issue 4, 2003, Pages 96-100
|
|
Antiretroviral therapy-related hepatotoxicity: predictors and clinical management.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ASPARTATE AMINOTRANSFERASE;
PROTEINASE INHIBITOR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
BLOOD;
CD4 LYMPHOCYTE COUNT;
CHEMICALLY INDUCED DISORDER;
ENZYMOLOGY;
GROWTH, DEVELOPMENT AND AGING;
HEPATITIS B VIRUS;
HEPATITIS C VIRUS;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LIVER DISEASE;
METABOLISM;
REVIEW;
RISK FACTOR;
VIROLOGY;
ALANINE TRANSAMINASE;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
ASPARTATE AMINOTRANSFERASES;
CD4 LYMPHOCYTE COUNT;
HEPACIVIRUS;
HEPATITIS B VIRUS;
HIV;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HUMANS;
LIVER DISEASES;
REVERSE TRANSCRIPTASE INHIBITORS;
RISK FACTORS;
|
|
EID: 15544378202
PISSN: 14620308
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (8)
|
|
References (30)
|
